Animal Healthcare Industry

A Free sample background from www.awesomebackgrounds.
com Slide 1
Notice:
“ statements and conclusions in this
presentation reflect personal experience -
are subjective, and may not apply to

everyone”
This presentation contains subject

matter which may cause extreme
pleasure and uncontrollable urges
to become an entrepreneur – VIEWER
DISCRETION IS ADVISED!
© 2006 By Default!
A Free sample background from www.awesomebackgrounds.com Slide 2
-Pharmaceutical industry is
growing at a rate of 11.42 %
Source :McKinsey
Wall street Journal – 7th Jan 2009
-2009 global pharmaceutical

sales will be more than $750
billion
Source : IMS ORG
Wall Street Journal - 22 hours ago
© 2006 By Default!
“There are lot many hands behind making previous

statement a universal truth and all are acknowledged
with time except for few which are constantly
contributing to the success of Pharmaceutical
Industry but its presence is not felt yet”
© 2006 By Default!
We are one among them !
© 2006 By Default!
Animal Healthcare Industry:Niche

Market Analysis
By: Abhishek Singh

2nd Sem MBA(Pharma)
Niper (Mohali)
© 2006 By Default!
Tide of Presentation
 Pharmaceutical human Healthcare market

Vs Pharmaceutical animal health care
market
 Animal health care Market an overview
 Business trends in the industry
 Forces shaping the future
 Hidden snap shot of the industry
 Conclusion
© 2006 By Default!
Pharmaceutical Human
Healthcare Market Vs
Pharmaceutical Animal
Healthcare market
 Disparities
Global Market Value
 Global Sales of Leading companies
 Global Sales of Leading Brand
 Key Findings
© 2006 By Default!
Disparities:
The global market for human pharmaceuticals is
worth 40-times more than its veterinary equivalent.
 Sales generated by the world’s leading human

pharmaceutical company are 20-times higher than
those of the biggest veterinary products business.
 There is a 30-fold difference between the research

spending capacity of the market leaders in the two
Sectors.
 The top-ranked human pharmaceutical company

employs more research scientists than the world’s
20 leading animal health businesses put together.
© 2006 By Default!
Global Market Value

700
600 Human
Pharmaceutica
l Source: IMS
500
Health
400
Veterinary
300 Medicines
Source: Wood
200 Mackenzie
100
0
US$(billions)
© 2006 By Default!
Global sales of leading company

50
45
Human
40 Pharmaceutica
35 l Source:
Pfizer
30
25
Veterinary
20 Medicines
15 Source: Pfizer
10
5
0
US$(billions)
© 2006 By Default!
Global sales of leading brand

14
12 Human
Pharmaceutica
l Source:
10
Pfizer
8
Veterinary
6 Medicines
Source: Merial
4 Merck
0
US$(billions)
© 2006 By Default!
Key Findings From Balance Sheet of

major players
 Schering & Plough.doc

 Wyeth Annual Report.doc
 Eli Lilly Annual Report.doc
 Verbec annual report.doc
© 2006 By Default!
Animal Healthcare market : An

overview
 Mapping the vet and pet market

 Indian Market
 Product categories
 Regulatory status
© 2006 By Default!
Mapping the vet and pet market
 Structure of World Market by Product

 Structure of World Market by Species
 Structure of World Market by
Company
© 2006 By Default!
Structure of World Market by

Product
Product Group 2008 share

$m
Medicinal feed additives ... ...2,150 … .11.2
Biological ... . .4,725 … .24.6
Anti-infectives ... ... 2,905 … .15.1
Parasiticides ... ... 5,450 … .28.4
Other pharmaceuticals ... ...3,960 … .20.6
Total 19,190 100.0
Source: Vetnosis Limited (2009)
© 2006 By Default!

Species
species 2008 share

$m %
Cattle ... . .5,135 .26.8

Sheep ….. .920 ... ...4.8
Pigs ... ...3,135 . .16.3
Poultry ... .2,065. .10.8
Companion animal / Other .7,935... .41.3
total 19,190 100.0
Source: Vetnosis Limited (2009)
© 2006 By Default!

Company
Animal health market
Pie Chart
Rank Companies Sales 2007 Market
MUSD share

1 Schering-Plough 2,710 15.1%
2 Pfizer 2,639 14.7%
3 Merial(*) 2,449 13.7%
4 Bayer(1) 1,308 7.3%
5 Fort Dodge(#) 1,042 5.8%
6 Elanco (eli lilly ltd) 996 5.6%
7 Novartis(1) 990 5.5%
8 Virbac(1) 600 3.3%
9 Boehringer Ingelheim 558 3.1%
10 CEVA(1) 460 2.6%
(1)excluding non animal health business ( *) Merck and Sanofi-Aventis,
(#) Animal Health Care Wyeth
Source: Vetnosis, formerly the animal health
business of Wood Mackenzie 2007
© 2006 By Default!
Distribution of sales in percentage
France
Rest of
10% 7% 22% Europe
5%
North america
7%
Latin America
17% 32%
Africa &
Middle East
Asia
Pacific
© 2006 By Default!
Indian Market
 The total Indian animal health market is
approximately Rs 1157 crore
Source: Animal Pharm Scrip reports (2006-07)
 Poultry sector accounts for a whopping 38% of the animal
healthcare market.
Source: Interlink Consultancy
The total exports from India for animal healthcare are INR 188.93
mn.
 The table below shows the exports of vaccines (in INR mn) in 2005-06 and
2006-07.
Commodity 2005-2006 2006-2007

Vaccines for veterinary medicine 251.26 188.93
Veterinary medicinal preparations 234.87 289.98
Source: Ministry of Commerce, India
© 2006 By Default!
Merger & acquisition
GlaxoSmithKline (GSK) Pharmaceuticals sold its animal health business to the French
animal-health and veterinary products company Virbac for a consideration of Rs 207.1
crore
Ranbaxy Laboratories divested its allied businesses that included its animal healthcare
business to ICICI Venture Funds
Netherlands-based animal nutrition company Provimi acquired the animal health

division of Unichem Laboratories.
Nicholas Piramal India Ltd (NPIL) has signed a long-term contract manufacturing
agreement with Pfizer International LLC for animal health products.
Wockhardt plans to raise around Rs 150 crore from the sale of the animal healthcare
business. Source:7 Apr 2009, 0114 hrs IST, ET Bureau
Charak Pharma is in an advanced stage of negotiation with Swiss multinational

Novartis India for a strategic tie-up for the animal healthcare business.
Source: Business Standard Thursday, Apr 23, 2009
Pfizer might trim animal health unit to clear Wyeth deal
© 2006 By Default!
Product categories
 Companion Animals
 Food Producing Animals
 Specialized Products
© 2006 By Default!
Companion Animal
Dogs
animal\Products for Dog.docx
Equine
Horses have always been a close companion of
humans since historic times
Cats
animal\Products for Cat.docx
C:\Users\abhisheksingh\Desktop\animal\Bayer Animal Health Products.docx

© 2006 By Default!
Food Producing Animals

A swine and poultry production is an intensive one,
most of the medication is given to groups of animals
either incorporated in feed or in the drinking water.
Treatments to dairy cattle and grazing animals are
individual ones: the mode of application and duration of
activity are key drivers of the pharmaceutical
development animal\Products for Cattle.docx
Cattle, sheep, swine and poultry represent
two thirds of the total veterinary market
“If the bee disappeared off the surface of the globe,
then man would only have four years left to live. No
bees, no pollination, no plants, no animals, no man.”
Albert Einstein
Aquaculture is extremely important as it represents
the solution to preserve wild fish populations.
© 2006 By Default! animal\Product for other livestock.docx

Specialized Product
Genetic tool helps avoid horned cattle
17 Mar 2009
Merial's genetic profiling technology means
that herd managers can know for certain the
horned status of their cattle when breeding
replacements.
Second trial shows cattle E coli O157 vaccine effe
ctive
18 Mar 2009
Commercial trial shows that Bioniche's Econiche
vaccine reduced the colonization of E coli O157 in
vaccinated cattle by 92%.
© 2006 By Default!
Regulatory Status
Veterinary Council Of India

(A statutory body established under Ministry of Agriculture,
Government of India)
© 2006 By Default!
Business trends in the industry

 Clutch of drug companies exiting from their
animal health businesses, making way
instead for dedicated players in the same
segment.
 Companies have made a big investment in

R&D for dogs and cats. Pfizer Animal Health
apportioned about $270 million in 2005.
Intervet allots 10% of sales to R&D, and
Merial spends 6-10% of sales.
© 2006 By Default!
Forces shaping the future

Average development journey for a veterinary
product is five to nine years.
Companies that develop drugs for humans need

be concerned with only one species when
picking their projects, whereas animal health
companies have numerous options.
"Human trials are typically 3,000-10,000

human patients, and animal trials are
maybe 300 animal patients.“
© 2006 By Default!
Combination treatments are another category of product

development. Heinen points to a new entry in Bayer's Advantage
line of flea products. Advantage Multi is an external, spot
application that extends beyond flea control to include, in the same
applicator, medicines to prevent heartworm and gastrointestinal
nematodes in cats and dogs.
© 2006 By Default!
Hidden snap shot of the industry

Advantage was the third best-selling consumer product in Bayer's
portfolio, behind only aspirin and a diabetes drug
humans have also benefited from drugs originally created
for animals e.g Ivermectin(ivermectin as Mectizan to treat
humans with onchocerciasis) by Merck
viruses and bacteria are species-specific, it is rare to be
able to transfer to animals a vaccine that was developed for
humans and vice versa. Rabies vaccines are one
prominent exception.
© 2006 By Default!
"There is huge potential for feline products, but the

industry doesn't have a grasp on that because cats
are sometimes difficult to deal with," "there are more
cats in the U.S. than dogs."
active ingredients responsible for blockbuster human drugs simply

need to be reformulated to be ready for animals. Reconcile,
nicknamed "puppy Prozac," and some nonsteroidal anti-
inflammatory drugs are examples.
Researchers also can get unexpected tips from clinical trials of
drugs intended for human use. In the case of Pfizer's Slentrol,
company researchers were investigating a microsomal triglyceride
transfer-protein-inhibitor molecule to treat human atherosclerosis.
© 2006 By Default!
Conclusion
© 2006 By Default!
© 2006 By Default!
© 2006 By Default!

Animal Healthcare Industry

Enviado por

Dados do documento

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

Animal Healthcare Industry

Enviado por

Direitos autorais:

Formatos disponíveis

A Free sample background from www.awesomebackgrounds.

are subjective, and may not apply to

This presentation contains subject

-2009 global pharmaceutical

“There are lot many hands behind making previous

We are one among them !

Animal Healthcare Industry:Niche

By: Abhishek Singh

 Pharmaceutical human Healthcare market

 Sales generated by the world’s leading human

 There is a 30-fold difference between the research

 The top-ranked human pharmaceutical company

Global Market Value

Global sales of leading company

Global sales of leading brand

Key Findings From Balance Sheet of

 Schering & Plough.doc

Animal Healthcare market : An

 Mapping the vet and pet market

Mapping the vet and pet market

 Structure of World Market by Product

Structure of World Market by

Product Group 2008 share

Total 19,190 100.0

Source: Vetnosis Limited (2009)

Structure of World Market by

species 2008 share

Cattle ... . .5,135 .26.8

total 19,190 100.0

Source: Vetnosis Limited (2009)

Structure of World Market by

Distribution of sales in percentage

Veterinary medicinal preparations 234.87 289.98

Source: Ministry of Commerce, India

Netherlands-based animal nutrition company Provimi acquired the animal health

Charak Pharma is in an advanced stage of negotiation with Swiss multinational

Source: Business Standard Thursday, Apr 23, 2009

Pfizer might trim animal health unit to clear Wyeth deal

 Food Producing Animals

C:\Users\abhisheksingh\Desktop\animal\Bayer Animal Health Products.docx

Food Producing Animals

Veterinary Council Of India

Business trends in the industry

 Companies have made a big investment in

Forces shaping the future

Companies that develop drugs for humans need

"Human trials are typically 3,000-10,000

Combination treatments are another category of product

Hidden snap shot of the industry

"There is huge potential for feline products, but the

active ingredients responsible for blockbuster human drugs simply

Você também pode gostar